Merck & Co. (MRK)

EBITDA Growth

-44.38%

TTM · Period ending:

MRK logo

MRK EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-44.38%
MRK TTM EBITDA YoY % (42.95% → -44.38%)
High-resolution chart · PNG

MRK ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Merck & Co. EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
15.9271%
20.0977%
22.2763%
17.9815%
11.0531%
14.2274%
18.2338%
9.4665%
24.7672%
16.9635%
10.3032%
19.9534%
8.3368%
10.7249%
13.3462%
14.6636%
15.3094%
14.3022%
12.3297%
7.1207%
4.6284%
1.6411%
-0.3333%
-0.4915%
3.4826%
30.8787%
35.8957%
79.0318%
78.9887%
13.6002%
11.2903%
-14.4729%
-15.2522%
7.9506%
7.7058%
9.7694%
10.6172%
15.9636%
22.2637%
24.1359%
24.1497%
-14.5998%
-38.1756%
110.8968%
16.5181%
65.8789%
129.73%
-43.1798%
7.2684%
18.0837%
36.3424%
21.9522%
31.8468%
37.6624%
31.5021%
40.5008%
42.9471%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.